pubmed-article:10811678 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10811678 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
pubmed-article:10811678 | lifeskim:mentions | umls-concept:C0035608 | lld:lifeskim |
pubmed-article:10811678 | lifeskim:mentions | umls-concept:C0332161 | lld:lifeskim |
pubmed-article:10811678 | lifeskim:mentions | umls-concept:C0199176 | lld:lifeskim |
pubmed-article:10811678 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:10811678 | lifeskim:mentions | umls-concept:C1533693 | lld:lifeskim |
pubmed-article:10811678 | lifeskim:mentions | umls-concept:C0206034 | lld:lifeskim |
pubmed-article:10811678 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:10811678 | pubmed:dateCreated | 2000-6-15 | lld:pubmed |
pubmed-article:10811678 | pubmed:abstractText | To determine whether the addition of rifampin to a quinolone-based antibacterial prophylactic regimen in patients undergoing high-dose chemotherapy (HDC) with peripheral-blood stem-cell transplantation (PBSCT) decreases the incidence of neutropenia and fever, Gram-positive bacteremia, and infection-related morbidity. | lld:pubmed |
pubmed-article:10811678 | pubmed:language | eng | lld:pubmed |
pubmed-article:10811678 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10811678 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10811678 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10811678 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10811678 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10811678 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10811678 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10811678 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10811678 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10811678 | pubmed:month | May | lld:pubmed |
pubmed-article:10811678 | pubmed:issn | 0732-183X | lld:pubmed |
pubmed-article:10811678 | pubmed:author | pubmed-author:HidalgoMM | lld:pubmed |
pubmed-article:10811678 | pubmed:author | pubmed-author:RodriguezMM | lld:pubmed |
pubmed-article:10811678 | pubmed:author | pubmed-author:Cortés-FunesH... | lld:pubmed |
pubmed-article:10811678 | pubmed:author | pubmed-author:SalazarRR | lld:pubmed |
pubmed-article:10811678 | pubmed:author | pubmed-author:LumbrerasCC | lld:pubmed |
pubmed-article:10811678 | pubmed:author | pubmed-author:SoláCC | lld:pubmed |
pubmed-article:10811678 | pubmed:author | pubmed-author:PerduDD | lld:pubmed |
pubmed-article:10811678 | pubmed:author | pubmed-author:HornedoJJ | lld:pubmed |
pubmed-article:10811678 | pubmed:author | pubmed-author:ArcedianoAA | lld:pubmed |
pubmed-article:10811678 | pubmed:author | pubmed-author:ValentíVV | lld:pubmed |
pubmed-article:10811678 | pubmed:author | pubmed-author:Gomez-MartinC... | lld:pubmed |
pubmed-article:10811678 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10811678 | pubmed:volume | 18 | lld:pubmed |
pubmed-article:10811678 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10811678 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10811678 | pubmed:pagination | 2126-34 | lld:pubmed |
pubmed-article:10811678 | pubmed:dateRevised | 2005-11-17 | lld:pubmed |
pubmed-article:10811678 | pubmed:meshHeading | pubmed-meshheading:10811678... | lld:pubmed |
pubmed-article:10811678 | pubmed:meshHeading | pubmed-meshheading:10811678... | lld:pubmed |
pubmed-article:10811678 | pubmed:meshHeading | pubmed-meshheading:10811678... | lld:pubmed |
pubmed-article:10811678 | pubmed:meshHeading | pubmed-meshheading:10811678... | lld:pubmed |
pubmed-article:10811678 | pubmed:meshHeading | pubmed-meshheading:10811678... | lld:pubmed |
pubmed-article:10811678 | pubmed:meshHeading | pubmed-meshheading:10811678... | lld:pubmed |
pubmed-article:10811678 | pubmed:meshHeading | pubmed-meshheading:10811678... | lld:pubmed |
pubmed-article:10811678 | pubmed:meshHeading | pubmed-meshheading:10811678... | lld:pubmed |
pubmed-article:10811678 | pubmed:meshHeading | pubmed-meshheading:10811678... | lld:pubmed |
pubmed-article:10811678 | pubmed:meshHeading | pubmed-meshheading:10811678... | lld:pubmed |
pubmed-article:10811678 | pubmed:meshHeading | pubmed-meshheading:10811678... | lld:pubmed |
pubmed-article:10811678 | pubmed:meshHeading | pubmed-meshheading:10811678... | lld:pubmed |
pubmed-article:10811678 | pubmed:meshHeading | pubmed-meshheading:10811678... | lld:pubmed |
pubmed-article:10811678 | pubmed:meshHeading | pubmed-meshheading:10811678... | lld:pubmed |
pubmed-article:10811678 | pubmed:meshHeading | pubmed-meshheading:10811678... | lld:pubmed |
pubmed-article:10811678 | pubmed:meshHeading | pubmed-meshheading:10811678... | lld:pubmed |
pubmed-article:10811678 | pubmed:meshHeading | pubmed-meshheading:10811678... | lld:pubmed |
pubmed-article:10811678 | pubmed:meshHeading | pubmed-meshheading:10811678... | lld:pubmed |
pubmed-article:10811678 | pubmed:meshHeading | pubmed-meshheading:10811678... | lld:pubmed |
pubmed-article:10811678 | pubmed:year | 2000 | lld:pubmed |
pubmed-article:10811678 | pubmed:articleTitle | Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial. | lld:pubmed |
pubmed-article:10811678 | pubmed:affiliation | Division of Medical Oncology, Microbiology, and Infectious Disease, Hospital Universitario "12 de Octubre," Madrid, Spain. | lld:pubmed |
pubmed-article:10811678 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10811678 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:10811678 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:10811678 | pubmed:publicationType | Multicenter Study | lld:pubmed |